Stock research
ENVB Enveric Biosciences, Inc.
Healthcare • Biotechnology
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for...…
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
3M change
-52.01%
Range high
$3.48
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in ENVB?
Price
Showing 3M history. Source: FMP historical price full.
- Prev Close
- $1.69
- Day High
- $1.68
- Day Low
- $1.55
- 52w High
- $17.64
- 52w Low
- $1.25
- Volume
- 410,638
- Avg Volume
- Beta
- 1.144
* TTM/most recent where available
Company
- Ticker
- ENVB
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Joseph Edward Tucker
- Employees
- 6
- Website
- www.enveric.com
Key Metrics
- Market Cap
- 997K
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).